(Q44239685)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12467746%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

title

High dose weekly oral prednisone improves strength in boys with Duchenne muscular dystrophy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12467746%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12467746%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

author name string

Jeanine Schierbecker

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12467746%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Renee Renna

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12467746%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Julaine Florence

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12467746%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

publication date

1 December 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12467746%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

published in

Neuromuscular Disorders

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12467746%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12467746%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12467746%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

page(s)

917-925

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12467746%20AND%20SRC:MED&resulttype=core&format=json

Prednisone in Duchenne muscular dystrophy

15 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900180-3

7 January 2021

Clinical investigation of Duchenne muscular dystrophy. Interesting results in a trial of prednisone

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900180-3

7 January 2021

Prednisone treatment in Duchenne muscular dystrophy. Long-term benefit

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900180-3

7 January 2021

Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900180-3

7 January 2021

A comparison of daily and alternate-day prednisone therapy in the treatment of Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900180-3

7 January 2021

Duchenne dystrophy: randomized, controlled trial of prednisone (18 months) and azathioprine (12 months)

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900180-3

7 January 2021

Long-term benefit from prednisone therapy in Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900180-3

7 January 2021

Deflazacort in Duchenne dystrophy: study of long-term effect

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900180-3

7 January 2021

Steroids in Duchenne muscular dystrophy; pilot study of a new low-dosage schedule

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900180-3

7 January 2021

75th European Neuromuscular Centre International Workshop: 2nd workshop on the treatment of muscular dystrophy 10-12 December, 1999, Naarden, The Netherlands.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900180-3

7 January 2021

Myoblast Transfer in the Treatment of Duchenne's Muscular Dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900180-3

7 January 2021

Neuropathy of metachromatic leukodystrophy: Improvement with immunomodulation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900180-3

7 January 2021

Primary alpha-sarcoglycan deficiency responsive to immunosuppression over three years

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900180-3

7 January 2021

Clinical evaluator reliability for quantitative and manual muscle testing measures of strength in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900180-3

7 January 2021

Physical growth: National Center for Health Statistics percentiles

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900180-3

7 January 2021

Bone mineral density and fractures in boys with Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900180-3

7 January 2021

Remission of clinical signs in early duchenne muscular dystrophy on intermittent low-dosage prednisolone therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900180-3

7 January 2021

Mononuclear cell analysis of muscle biopsies in prednisone- and azathioprine-treated Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900180-3

7 January 2021

Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900180-3

7 January 2021

Complement activation in muscle fiber necrosis: demonstration of the membrane attack complex of complement in necrotic fibers

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900180-3

7 January 2021

10.1016/S0960-8966(02)00180-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12467746%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

1 reference